PTEN Hamartoma Tumor Syndrome Phenotyping

PTEN Hamartoma Tumor Syndrome Phenotyping

Contact

 If you are interested in participating in the study or want to learn more, please get in touch. Contact us
This study is now recruiting. Learn more about enrolling here.

Description
Children and adults with PTEN Hamartoma Tumor Syndrome (PHTS) are at risk for specific long-term medical complications including autism spectrum disorder and cancer. While protocols for cancer screening exist, we do not yet have protocols for screening other complications of this syndrome, including neurobehavioral differences and immunologic changes. This pilot study will assess these outcomes in children and young adults with PHTS ages 1 to 20 years.

Eligibility and criteria
IRB Number:
20-017722
Eligible age range:
1 years - 20 years
Clinical trial phase:
N/A
Official title:
Phenotypic Features of Pediatric PTEN Hamartoma Tumor Syndrome

Related specialties
Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.